Net Cash Provided by (Used in) Operating Activities |
3.36M |
USD |
+76.7% |
Q3 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
-1.1M |
USD |
-73.4% |
Q3 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-740K |
USD |
+46.5% |
Q3 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
4M |
shares |
0% |
Q4 2024 |
Q2 2025 |
Common Stock, Shares, Issued |
3.46M |
shares |
0% |
Q4 2024 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2024 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
1.52M |
USD |
|
Q3 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
14.4M |
USD |
+16.9% |
Q4 2024 |
Q2 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
23K |
USD |
-98.7% |
Q3 2023 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
36.5M |
USD |
+7.99% |
Q2 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
37.2M |
USD |
+5.98% |
Q2 2024 |
FY 2024 |
Payments to Acquire Property, Plant, and Equipment |
269K |
USD |
-64.3% |
Q3 2024 |
Q1 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
14.5M |
USD |
+10% |
Q2 2024 |
FY 2024 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q4 2024 |
Q2 2025 |
Preferred Stock, Shares Authorized |
100K |
shares |
0% |
Q4 2024 |
Q2 2025 |
Unrecognized Tax Benefits |
1.67M |
USD |
0% |
Q2 2024 |
FY 2024 |
Additional Paid in Capital |
3.57M |
USD |
+1.71% |
Q4 2024 |
Q2 2025 |
Depreciation, Depletion and Amortization |
1.67M |
USD |
+9.59% |
Q3 2024 |
Q1 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
1.31M |
USD |
-66.5% |
Q2 2023 |
FY 2023 |
Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2024 |
Q2 2025 |